[Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma].

MLA

Oshiro, Shinya, et al. “[Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma].” No Shinkei Geka. Neurological Surgery, vol. 45, no. 6, June 2017, pp. 509–17. EBSCOhost, https://doi.org/10.11477/mf.1436203541.

APA

Oshiro, S., Wakuta, N., Kawai, S., Miki, K., & Shigemori, Y. (2017). [Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma]. No Shinkei Geka. Neurological Surgery, 45(6), 509–517. https://doi.org/10.11477/mf.1436203541

Chicago

Oshiro, Shinya, Naoki Wakuta, Shinichi Kawai, Koichi Miki, and Yutaka Shigemori. 2017. “[Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma].” No Shinkei Geka. Neurological Surgery 45 (6): 509–17. doi:10.11477/mf.1436203541.